Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial In a series of three adjuvant trials, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results